Gain Therapeutics Inc. (GANX): Rasio kapitalisasi marang pendapatan

Simbol lan logo merek Gain Therapeutics Inc. (GANX)

Gain Therapeutics, Inc. (GANX) develops treatments for neurodegeneration by utilizing supercomputer analysis to identify enzyme regulators. High patent barriers and stringent FDA oversight protect the company's developments. The startup is currently focusing on clinical trials for a Parkinson's disease drug. This price-to-sales chart reflects the business valuation trend, with the current ratio standing at 653.80.

GANX: Kapitalisasi marang pendapatan Gain Therapeutics Inc. 04.07.2022 - 14.05.2024

Rincian analitis perusahaan gaintherapeutics.com (GANX)

Analisis fundamental perusahaan:Gain Therapeutics, Inc., GANX
Produk dadi Gain Therapeutics, Inc.

Complex bio-logistics and cold chain supply management drive the operational costs of Gain Therapeutics, Inc. By analyzing the company's normalized P/S ratio, an investor assesses market capitalization relative to generated revenue. This ratio is calculated by dividing the total business value by annual revenue, measuring the premium for future growth. The trend of this indicator helps determine the extent of the asset's overvaluation or the potential for a fundamental correction.

Perusahaan pesaing

HCA (HCA Healthcare) - Rasio kapitalisasi pasar marang pendapatan|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Fresenius Medical (FMS) - Rega marang dodolan|Solventum Corp - Multiplikator P/S|Rasio rega marang dodolan EHC|Universal Health Services (UHS) - Rasio rega marang pendapatan|DaVita - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RDNT|OPCH: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Rasio kapitalisasi pasar marang pendapatan|National Vision - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Progyny Inc (PGNY)|Ardent Health - Multiplikator P/S|Koefisien rega marang pendapatan Select Medical Corp SEM|ASTH: Multiplikator P/S|Rasio kapitalisasi marang pendapatan MD|USPH (US Physical Therapy Inc) - Multiplikator P/S|PNTG: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rega marang dodolan|EOLS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan MDWD|Rasio rega marang pendapatan biote Corp.|Rega marang dodolan thejoint.com JYNT|Multiplikator P/S DCGO|Kapitalisasi marang pendapatan P3 Health PIII|Multiplikator P/S EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Rasio rega marang dodolan|CLGN - Rasio rega marang pendapatan|Rega marang dodolan cuprina.com.sg|CCM: Multiplikator P/S|AMS: Kapitalisasi marang volume dodolan|MRM (MEDIROM Corp) - Multiplikator P/S|ALBT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DHAI|Longevity Health Holdings - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Rasio rega marang dodolan|CMAX: Kapitalisasi marang pendapatan|Rega marang dodolan Kindly Health|ModivCare (MODV) - Rasio rega marang pendapatan|NVOS (novointegrated.com) - Rasio rega marang pendapatan|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|BACK (IMAC Holdings Inc) - Kapitalisasi marang volume dodolan